Emergence of W135 meningococcal meningitis in Ghana
- 1 December 2005
- journal article
- Published by Wiley in Tropical Medicine & International Health
- Vol. 10 (12), 1229-1234
- https://doi.org/10.1111/j.1365-3156.2005.01520.x
Abstract
Neisseria meningitidis serogroup W135, well known for a long time as a cause of isolated cases of meningococcal meningitis, has recently increasingly been associated with disease outbreaks of considerable magnitude. Burkina Faso was hit by W135 epidemics in the dry seasons of 2002-2004, but only four W135 meningitis cases were recorded between February 2003 and March 2004 in adjoining Ghana. This reconfirms previous findings that bottlenecks exist in the spreading of new epidemic N. meningitidis clones within the meningitis belt of sub-Saharan Africa. Of the four Ghanaian W135 meningitis patients one died and three survived, of whom one had profound neurosensory hearing loss and speech impairment. All four disease isolates were sensitive to penicillin G, chloramphenicol, ciprofloxacin and cefotaxime and had the multi-locus sequence type (ST) 11, which is the major ST of the ET-37 clonal complex. Pulsed-field gel electrophoresis (PFGE) profiles of the Ghanaian disease isolates and recent epidemic isolates from Burkina Faso were largely identical. We conducted meningococcal colonization surveys in the home communities of three of the patients and in the Kassena Nankana District located at the border to Burkina Faso. W135 carriage rates ranged between 0% and 17.5%. When three consecutive surveys were conducted in the patient community with the highest carrier rate, persistence of W135 colonization over a period of 1 year was observed. Differences in PFGE profiles of carrier isolates taken at different times in the same patient community were indicative of rapid microevolution of the W135 bacteria, emphasizing the need for innovative fine typing methods to reveal the relationship between W135 isolatesKeywords
This publication has 23 references indexed in Scilit:
- Continuing Diversification of Neisseria meningitidis W135 as a Primary Cause of Meningococcal Disease after Emergence of the Serogroup in 2000Journal of Clinical Microbiology, 2004
- PCR-Based Assay for Detection of Neisseria meningitidis Capsular Serogroups 29E, X, and ZJournal of Clinical Microbiology, 2004
- Outbreak of W135 Meningococcal Disease in 2000: Not Emergence of a New W135 Strain but Clonal Expansion within the Electophoretic Type–37 ComplexThe Journal of Infectious Diseases, 2002
- Prospective Study of a Serogroup XNeisseria meningitidisOutbreak in Northern GhanaThe Journal of Infectious Diseases, 2002
- Neisseria meningitidis Serogroups W135 and A Were Equally Prevalent among Meningitis Cases Occurring at the End of the 2001 Epidemics in Burkina Faso and NigerJournal of Clinical Microbiology, 2002
- Pneumococcal Surface Protein A of InvasiveStreptococcus pneumoniaeIsolates from Colombian ChildrenEmerging Infectious Diseases, 2001
- Neisseria meningitidis serogroup W135 isolates associated with the ET-37 complex.Emerging Infectious Diseases, 2000
- Meningococcal meningitis in AfricaTransactions of the Royal Society of Tropical Medicine and Hygiene, 1999
- PCR Identification of the Group A Neisseria Meningitidis Gene in Cerebrospinal FluidScandinavian Journal of Infectious Diseases, 1999
- EMERGENCE OF MENINGOCOCCAL MENINGITIS CAUSED BY W135 SEROGROUP IN AFRICAThe Lancet, 1982